Relapsed Hodgkin's Disease, Adult
5 clinical trials · Condition
◉ Watch Relapsed Hodgkin's Disease, Adult
| Record | Firm | Date |
|---|---|---|
| Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and Lymphoma (NCT05346809) | Divaya Bhutani | 2023-03-31 |
| Treatment Strategy for Relapsed/Refractory Hodgkin Lymphoma (NCT05595447) | Hospital Regional de Alta Especialidad del Bajio | 2022-10-18 |
| Ipilimumab With or Without Nivolumab in Relapsed/Refractory cHL (NCT04938232) | Dana-Farber Cancer Institute | 2021-06-04 |
| RWE of Brentuximab Vedotin Consolidation in Patients With RR HL Who Receive Salvage Chemotherapy and ASCT (NCT04776265) | Grupo Argentino de Tratamiento de la Leucemia Aguda | 2021-06-01 |
| Interest of a Systematic One-year Monitoring by 18F-FDG PET-CT (NCT04464590) | University Hospital, Brest | 2009-01-01 |
Track Relapsed Hodgkin's Disease, Adult automatically
Every clearance here is in the API, with alerts when new ones post.